Trends in the identification and treatment of ALS are expected to lead to a significant increase in clinic demand over the ...
A clinical trial in Europe is testing the safety and pharmacological properties of LTX-002 as a potential treatment for ALS. The new therapy targets dysregulated fat metabolism, a key contributor to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results